Sutimlimab
Sutimlimab is a novel monoclonal antibody targeting complement protein C1. Sutimlimab is commonly used as a C1 inhibitor to treat cold agglutina-associated hemolysis.
Product Specifications
CAS Number
2049079-64-1
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Complement System
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
P100819_T100-HRP 100 µL
NFIC Antibody - C-terminal region : HRP (P100819_T100-HRP)
Sign In for Pricing
View Details 
RR210252L3V 200 µL
Psma4 (NM_017281) Rat Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details